Phase II trial of BP GMAX CD1 in patients with prostate cancer.

Trial Profile

Phase II trial of BP GMAX CD1 in patients with prostate cancer.

Planning
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2012

At a glance

  • Drugs BPX 101 (Primary) ; Rimiducid
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2012 Planned initiation date changed from 1 Dec 2011 to 9 Sep 2011 based on information reported in a Bellicum media release.
    • 21 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top